IN2014CH01872A - - Google Patents

Info

Publication number
IN2014CH01872A
IN2014CH01872A IN1872CH2014A IN2014CH01872A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A IN 1872CH2014 A IN1872CH2014 A IN 1872CH2014A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A
Authority
IN
India
Prior art keywords
nanodispersion
present disclosure
exemplary embodiment
aqueous dispersion
dispersion medium
Prior art date
Application number
Other languages
English (en)
Inventor
Rambhau Devraj
Pranati CHHATOI
Naga Hemanth Kumar PARVATHABHATLA
Anand Vasant DESHMUKH
Krishna Kaushik CHINTABHATLA
Original Assignee
Nanoceutica Lab Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanoceutica Lab Pvt Ltd filed Critical Nanoceutica Lab Pvt Ltd
Priority to EA201692044A priority Critical patent/EA038458B1/ru
Priority to US15/302,495 priority patent/US11458096B2/en
Priority to PCT/IB2015/052541 priority patent/WO2015155703A2/en
Priority to MX2016013201A priority patent/MX2016013201A/es
Priority to IN1872CH2014 priority patent/IN2014CH01872A/en
Priority to AU2015246030A priority patent/AU2015246030B2/en
Priority to EP15777362.3A priority patent/EP3129002A4/en
Publication of IN2014CH01872A publication Critical patent/IN2014CH01872A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
IN1872CH2014 2014-04-09 2015-04-08 IN2014CH01872A (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EA201692044A EA038458B1 (ru) 2014-04-09 2015-04-08 Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения
US15/302,495 US11458096B2 (en) 2014-04-09 2015-04-08 Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
PCT/IB2015/052541 WO2015155703A2 (en) 2014-04-09 2015-04-08 Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
MX2016013201A MX2016013201A (es) 2014-04-09 2015-04-08 Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa.
IN1872CH2014 IN2014CH01872A (es) 2014-04-09 2015-04-08
AU2015246030A AU2015246030B2 (en) 2014-04-09 2015-04-08 Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
EP15777362.3A EP3129002A4 (en) 2014-04-09 2015-04-08 Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1872CH2014 IN2014CH01872A (es) 2014-04-09 2015-04-08

Publications (1)

Publication Number Publication Date
IN2014CH01872A true IN2014CH01872A (es) 2015-05-08

Family

ID=54288490

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1872CH2014 IN2014CH01872A (es) 2014-04-09 2015-04-08

Country Status (7)

Country Link
US (1) US11458096B2 (es)
EP (1) EP3129002A4 (es)
AU (1) AU2015246030B2 (es)
EA (1) EA038458B1 (es)
IN (1) IN2014CH01872A (es)
MX (1) MX2016013201A (es)
WO (1) WO2015155703A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2540054B (en) 2014-04-30 2017-07-12 Matoke Holdings Ltd Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
FR3075661A1 (fr) 2017-12-21 2019-06-28 Coatex Emulsion submicronique
WO2019175830A1 (en) * 2018-03-14 2019-09-19 Azista Industries Pvt Ltd Cholecalciferol nanoemulsion formulations and methods for producing same
WO2023118928A1 (en) 2021-12-21 2023-06-29 Opella Healthcare Group Sas Stable nanoformulation for lipophilic actives, oral dosage form and process for its preparation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US5518738A (en) 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
AU6708096A (en) 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
DE19642359A1 (de) 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
US5994414A (en) 1997-04-28 1999-11-30 Avon Products, Inc. Water-thin emulsion formed by high pressure homogenization process
EP1249230B1 (de) * 2001-04-12 2003-11-05 Vesifact Ag Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen
US6780324B2 (en) 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
CA2486553C (en) 2002-06-17 2012-01-10 Taro Pharmaceuticals U.S.A., Inc. Ibuprofen suspension
US8628690B2 (en) 2004-02-23 2014-01-14 The Texas A&M University System Nanoemulsion compositions and methods of use thereof
EP1597973A1 (en) 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
US8318181B2 (en) 2005-12-01 2012-11-27 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
CA2645080A1 (en) 2006-03-07 2007-09-13 Novavax,Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
EP1938801A1 (en) 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
WO2009067734A1 (en) 2007-11-28 2009-06-04 Commonwealth Scientific And Industrial Research Organisation Nanoemulsions
WO2009070642A1 (en) * 2007-11-28 2009-06-04 Medimmune, Llc Protein formulation
WO2010075537A1 (en) 2008-12-23 2010-07-01 Teva Pharmaceutical Industries Ltd. Formulations comprising vitamin d or derivatives thereof
NZ595204A (en) 2009-03-09 2014-11-28 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
CA2762179A1 (en) * 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
KR20120050414A (ko) * 2009-06-19 2012-05-18 썬 파마 어드밴스트 리서치 컴패니 리미티드 약물의 나노분산액 및 그의 제조 방법
WO2011075623A1 (en) * 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
EP2544663B1 (en) * 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
SE536746C2 (sv) 2010-05-12 2014-07-08 Stora Enso Oyj En komposition innehållande mikrofibrillerad cellulosa och en process för tillverkning av en komposition
US8835509B2 (en) 2010-05-31 2014-09-16 Arbro Pharmaceuticals Ltd. Self emulsifying drug delivery system for a curcuminoid based composition
EP2613766A4 (en) 2010-09-08 2014-04-09 Pronova Biopharma Norge As COMPOSITIONS COMPRISING AN OIL MIXTURE CONSISTING OF FATTY ACIDS COMPRISING EPA AND DHA AS FREE ACID, SURFACTANT AND STATIN
WO2013008083A1 (en) 2011-07-13 2013-01-17 National Institute Of Pharmaceutical Education And Research (Niper) Pharmaceutical composition for enhancing anticancer efficacy of tamoxifen
NZ596015A (en) 2011-10-26 2014-04-30 Anzamed Internat Ltd Method and composition for the treatment of pain and/or inflammation
GB201204377D0 (en) 2012-03-13 2012-04-25 Givaudan Sa Composition

Also Published As

Publication number Publication date
AU2015246030B2 (en) 2020-03-12
MX2016013201A (es) 2017-04-25
US11458096B2 (en) 2022-10-04
WO2015155703A3 (en) 2015-12-30
EP3129002A2 (en) 2017-02-15
AU2015246030A1 (en) 2016-11-24
EA038458B1 (ru) 2021-08-31
EA201692044A1 (ru) 2017-04-28
WO2015155703A2 (en) 2015-10-15
EP3129002A4 (en) 2017-11-08
US20180177723A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
EP3548450A4 (en) FORMULATIONS WITH ACTIVE FUNCTIONAL ADDITIVES FOR 3D PRINTING PRECERAMIC POLYMERS AND METHODS FOR 3D PRINTING FORMULATIONS
IN2014CH01872A (es)
EP3215806A4 (en) 3d imaging, ranging, and/or tracking using active illumination and point spread function engineering
MX2019006158A (es) Sistemas polimerícos para dispersión de partículas.
EP3131937A4 (en) Aqueous dispersion and coating composition comprising the same
PL3229976T3 (pl) Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający tę dyspersję
EP3039049A4 (en) Self-crosslinkable polymer and aqueous dispersion comprising particles of the same
JP2015110565A5 (es)
HK1218626A1 (zh) 包含高水平水混溶性溶劑之疏水劑的基本上不含表面活性劑的亞微米分散體
MX2018014399A (es) Particulas de nanoalumbre que contienen un agente de dimensionamiento.
EP3562851A4 (en) AQUATIC POLYMER DISPERSION AND Aqueous coating composition therewith
EP3108869A4 (en) Aqueous dispersion of inorganic powder particles subjected to hydrophobic organic surface treatment, and cosmetic including same
WO2014160185A3 (en) Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
EP3608415A4 (en) POLYHYDROXY ALKANOATE PARTICLES AND AQUATIC DISPERSION OF THE SAME
PL3230336T3 (pl) Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający dyspersję
IL266018A (en) Methods and systems for improving the stability of the pre-vapor composition of an electronic inhalation device
EP3295943A4 (en) Aqueous suspension agent comprising glucocorticosteroid nanoparticles
WO2014172608A3 (en) Parthenolide derivatives and their modulation of processes controlled by regulated translation
PL3448902T3 (pl) Wodna dyspersja i jej zastosowania
EP3083282A4 (en) Tires and other objects having an aerodynamic/hydrodynamic surface treatment
EP3287786A3 (en) Compositions and methods for active surveillance of prostate cancer
EP3385326A4 (en) AQUEOUS DISPERSION OF POLYTETRAFLUOROETHYLENE
EP3546517A4 (en) AQUEOUS POLYTETRAFLUORETHYLENE DISPERSION
EP3510091A4 (en) SURFACE MODIFYING AGENT FORMULATION
EP2987405A4 (en) AGROCHEMICAL OIL DISPERSION FORMULATION, USE OF AGROCHEMICAL OIL DISPERSION FORMULATIONS AND METHOD FOR PRODUCING AN AGROCHEMICAL OIL DISPERSION FORMULATION